ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF

ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF

The present invention pertains to: an anti-cancer vaccine composition comprising [peptides derived from a tumor-associated antigen (TAA)] and [an adjuvant consisting of a lipopeptide and an immunoactive substance]; and a use thereof. Specifically, the peptides derived from a tumor-associated antigen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KO, Eunbyeol, JUNG, Eunjung, AHN, Byung Cheol, KIM, Hye-jung, CHUN, Eunyuong, YUM, Jung Sun, HEO, Yoonki
Format: Patent
Sprache:eng ; fre ; kor
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KO, Eunbyeol
JUNG, Eunjung
AHN, Byung Cheol
KIM, Hye-jung
CHUN, Eunyuong
YUM, Jung Sun
HEO, Yoonki
description The present invention pertains to: an anti-cancer vaccine composition comprising [peptides derived from a tumor-associated antigen (TAA)] and [an adjuvant consisting of a lipopeptide and an immunoactive substance]; and a use thereof. Specifically, the peptides derived from a tumor-associated antigen specifically bind to a human leucocyte antigen (HLA), a combination of the peptides having the above characteristics is mixed with the adjuvant in an optimal ratio to prepare a vaccine composition, and the vaccine composition is used for preventing or treating cancer. La présente invention concerne : une composition de vaccin anti-cancer comprenant des peptides dérivés d'un antigène associé à une tumeur (TAA) et un adjuvant consistant en un lipopeptide et une substance immunoactive ; et une utilisation de celle-ci. Spécifiquement, les peptides dérivés d'un antigène associé à une tumeur se lient spécifiquement à un antigène leucocytaire humain (HLA), une combinaison des peptides ayant les caractéristiques ci-dessus est mélangée avec l'adjuvant dans un rapport optimal pour préparer une composition de vaccin, et la composition de vaccin est utilisée pour prévenir ou traiter le cancer. 본 발명은 [종양 연관 항원(TAA) 유래 펩타이드] 및 [리포펩타이드와 면역활성물질로 구성된 아쥬번트]를 포함하는 항암 백신 조성물 및 이의 용도에 관한 것으로, 구체적으로, 본 발명의 종양 연관 항원 유래 펩타이드는 인간 백혈구 항원 (human leucocyte antigen: HLA)에 특이적으로 결합하는 펩타이드이고, 상기 특징을 가진 펩타이드 조합을 상기 아쥬번트와 최적의 비율로 혼합하여 백신 조성물을 제조하고, 이를 암의 예방 또는 치료에 사용하는 것이다.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023048530A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023048530A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023048530A13</originalsourceid><addsrcrecordid>eNqNzsFqwzAMBuBcdhjr3kHQ6wJZskKvnqO0GrUVLDk7hlLc01gL2WvtHedkfYCeJP38fOix-DVeqbTGWwwwGGvJI1h2PQspsV_2QEJ-Bz32Si0KtBhowBa6wA40Og6lEWFLRnM6izv0L3nJR_sRh5xkxwuJzg53cKCeb9xSI-eiZ2M1uyDxXXT-6J-IgqB7DMjdqng4H7-m9HybT8W6Q7X7Ml0vY5qux1P6Tj_jJ9dV3VRv201TmdfmvtYfawNJnA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF</title><source>esp@cenet</source><creator>KO, Eunbyeol ; JUNG, Eunjung ; AHN, Byung Cheol ; KIM, Hye-jung ; CHUN, Eunyuong ; YUM, Jung Sun ; HEO, Yoonki</creator><creatorcontrib>KO, Eunbyeol ; JUNG, Eunjung ; AHN, Byung Cheol ; KIM, Hye-jung ; CHUN, Eunyuong ; YUM, Jung Sun ; HEO, Yoonki</creatorcontrib><description>The present invention pertains to: an anti-cancer vaccine composition comprising [peptides derived from a tumor-associated antigen (TAA)] and [an adjuvant consisting of a lipopeptide and an immunoactive substance]; and a use thereof. Specifically, the peptides derived from a tumor-associated antigen specifically bind to a human leucocyte antigen (HLA), a combination of the peptides having the above characteristics is mixed with the adjuvant in an optimal ratio to prepare a vaccine composition, and the vaccine composition is used for preventing or treating cancer. La présente invention concerne : une composition de vaccin anti-cancer comprenant des peptides dérivés d'un antigène associé à une tumeur (TAA) et un adjuvant consistant en un lipopeptide et une substance immunoactive ; et une utilisation de celle-ci. Spécifiquement, les peptides dérivés d'un antigène associé à une tumeur se lient spécifiquement à un antigène leucocytaire humain (HLA), une combinaison des peptides ayant les caractéristiques ci-dessus est mélangée avec l'adjuvant dans un rapport optimal pour préparer une composition de vaccin, et la composition de vaccin est utilisée pour prévenir ou traiter le cancer. 본 발명은 [종양 연관 항원(TAA) 유래 펩타이드] 및 [리포펩타이드와 면역활성물질로 구성된 아쥬번트]를 포함하는 항암 백신 조성물 및 이의 용도에 관한 것으로, 구체적으로, 본 발명의 종양 연관 항원 유래 펩타이드는 인간 백혈구 항원 (human leucocyte antigen: HLA)에 특이적으로 결합하는 펩타이드이고, 상기 특징을 가진 펩타이드 조합을 상기 아쥬번트와 최적의 비율로 혼합하여 백신 조성물을 제조하고, 이를 암의 예방 또는 치료에 사용하는 것이다.</description><language>eng ; fre ; kor</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230330&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023048530A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25555,76308</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230330&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023048530A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KO, Eunbyeol</creatorcontrib><creatorcontrib>JUNG, Eunjung</creatorcontrib><creatorcontrib>AHN, Byung Cheol</creatorcontrib><creatorcontrib>KIM, Hye-jung</creatorcontrib><creatorcontrib>CHUN, Eunyuong</creatorcontrib><creatorcontrib>YUM, Jung Sun</creatorcontrib><creatorcontrib>HEO, Yoonki</creatorcontrib><title>ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF</title><description>The present invention pertains to: an anti-cancer vaccine composition comprising [peptides derived from a tumor-associated antigen (TAA)] and [an adjuvant consisting of a lipopeptide and an immunoactive substance]; and a use thereof. Specifically, the peptides derived from a tumor-associated antigen specifically bind to a human leucocyte antigen (HLA), a combination of the peptides having the above characteristics is mixed with the adjuvant in an optimal ratio to prepare a vaccine composition, and the vaccine composition is used for preventing or treating cancer. La présente invention concerne : une composition de vaccin anti-cancer comprenant des peptides dérivés d'un antigène associé à une tumeur (TAA) et un adjuvant consistant en un lipopeptide et une substance immunoactive ; et une utilisation de celle-ci. Spécifiquement, les peptides dérivés d'un antigène associé à une tumeur se lient spécifiquement à un antigène leucocytaire humain (HLA), une combinaison des peptides ayant les caractéristiques ci-dessus est mélangée avec l'adjuvant dans un rapport optimal pour préparer une composition de vaccin, et la composition de vaccin est utilisée pour prévenir ou traiter le cancer. 본 발명은 [종양 연관 항원(TAA) 유래 펩타이드] 및 [리포펩타이드와 면역활성물질로 구성된 아쥬번트]를 포함하는 항암 백신 조성물 및 이의 용도에 관한 것으로, 구체적으로, 본 발명의 종양 연관 항원 유래 펩타이드는 인간 백혈구 항원 (human leucocyte antigen: HLA)에 특이적으로 결합하는 펩타이드이고, 상기 특징을 가진 펩타이드 조합을 상기 아쥬번트와 최적의 비율로 혼합하여 백신 조성물을 제조하고, 이를 암의 예방 또는 치료에 사용하는 것이다.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzsFqwzAMBuBcdhjr3kHQ6wJZskKvnqO0GrUVLDk7hlLc01gL2WvtHedkfYCeJP38fOix-DVeqbTGWwwwGGvJI1h2PQspsV_2QEJ-Bz32Si0KtBhowBa6wA40Og6lEWFLRnM6izv0L3nJR_sRh5xkxwuJzg53cKCeb9xSI-eiZ2M1uyDxXXT-6J-IgqB7DMjdqng4H7-m9HybT8W6Q7X7Ml0vY5qux1P6Tj_jJ9dV3VRv201TmdfmvtYfawNJnA</recordid><startdate>20230330</startdate><enddate>20230330</enddate><creator>KO, Eunbyeol</creator><creator>JUNG, Eunjung</creator><creator>AHN, Byung Cheol</creator><creator>KIM, Hye-jung</creator><creator>CHUN, Eunyuong</creator><creator>YUM, Jung Sun</creator><creator>HEO, Yoonki</creator><scope>EVB</scope></search><sort><creationdate>20230330</creationdate><title>ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF</title><author>KO, Eunbyeol ; JUNG, Eunjung ; AHN, Byung Cheol ; KIM, Hye-jung ; CHUN, Eunyuong ; YUM, Jung Sun ; HEO, Yoonki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023048530A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; kor</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KO, Eunbyeol</creatorcontrib><creatorcontrib>JUNG, Eunjung</creatorcontrib><creatorcontrib>AHN, Byung Cheol</creatorcontrib><creatorcontrib>KIM, Hye-jung</creatorcontrib><creatorcontrib>CHUN, Eunyuong</creatorcontrib><creatorcontrib>YUM, Jung Sun</creatorcontrib><creatorcontrib>HEO, Yoonki</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KO, Eunbyeol</au><au>JUNG, Eunjung</au><au>AHN, Byung Cheol</au><au>KIM, Hye-jung</au><au>CHUN, Eunyuong</au><au>YUM, Jung Sun</au><au>HEO, Yoonki</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF</title><date>2023-03-30</date><risdate>2023</risdate><abstract>The present invention pertains to: an anti-cancer vaccine composition comprising [peptides derived from a tumor-associated antigen (TAA)] and [an adjuvant consisting of a lipopeptide and an immunoactive substance]; and a use thereof. Specifically, the peptides derived from a tumor-associated antigen specifically bind to a human leucocyte antigen (HLA), a combination of the peptides having the above characteristics is mixed with the adjuvant in an optimal ratio to prepare a vaccine composition, and the vaccine composition is used for preventing or treating cancer. La présente invention concerne : une composition de vaccin anti-cancer comprenant des peptides dérivés d'un antigène associé à une tumeur (TAA) et un adjuvant consistant en un lipopeptide et une substance immunoactive ; et une utilisation de celle-ci. Spécifiquement, les peptides dérivés d'un antigène associé à une tumeur se lient spécifiquement à un antigène leucocytaire humain (HLA), une combinaison des peptides ayant les caractéristiques ci-dessus est mélangée avec l'adjuvant dans un rapport optimal pour préparer une composition de vaccin, et la composition de vaccin est utilisée pour prévenir ou traiter le cancer. 본 발명은 [종양 연관 항원(TAA) 유래 펩타이드] 및 [리포펩타이드와 면역활성물질로 구성된 아쥬번트]를 포함하는 항암 백신 조성물 및 이의 용도에 관한 것으로, 구체적으로, 본 발명의 종양 연관 항원 유래 펩타이드는 인간 백혈구 항원 (human leucocyte antigen: HLA)에 특이적으로 결합하는 펩타이드이고, 상기 특징을 가진 펩타이드 조합을 상기 아쥬번트와 최적의 비율로 혼합하여 백신 조성물을 제조하고, 이를 암의 예방 또는 치료에 사용하는 것이다.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; kor
recordid cdi_epo_espacenet_WO2023048530A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title ANTI-CANCER VACCINE COMPOSITION COMPRISING PEPTIDES DERIVED FROM TUMOR-ASSOCIATED ANTIGEN, AND ADJUVANT CONSISTING OF LIPOPEPTIDE AND IMMUNOACTIVE SUBSTANCE, AND USE THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A45%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KO,%20Eunbyeol&rft.date=2023-03-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023048530A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true